Quantification of the migration assays revealed a significant reduction in the migratory ability of both U251 and LN229 glioma cells upon DAPK1 knockdown, supporting the notion that DAPK1 is essential for glioma cell migration (Figures 9D, E). Here, DAPK1 is linked to central nervous system cancer.